Thus, although the other identified biomarkers (MMP-1/MMP-3/SAA) contributed to the understanding of SDFR in RA, these biomarkers (individually or when combined) are apparently not essential for the clinical identification of these patients. Here, MMP3 is linked to rheumatoid arthritis.